Status:
COMPLETED
The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.
Lead Sponsor:
Region Skane
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with severe hypoxemic respiratory failure due to Covid-19 are often treated with oxygen delivered through a high-flow nasal cannula (HFNC). This is according to guidelines. We have made the c...
Detailed Description
Patients with severe covid-19, treated with HFNC, will be approached for consent. If inclusion critera and no exclusion criteria are fulfilled, baseline measurements will be taken without mask, includ...
Eligibility Criteria
Inclusion
- Verified Covid19 infection
- treatment with HFNC
- Estimated P/F ratio of ≤ 13 KPa
Exclusion
- language barrier
- unable to provide consent
- risk of deterioration due to study
Key Trial Info
Start Date :
February 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04794400
Start Date
February 4 2021
End Date
March 31 2021
Last Update
June 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skåne University Hospital
Malmo, Skåne County, Sweden, 20502